Skip to main content
Top
Published in: Surgical Endoscopy 1/2017

01-01-2017

Retrospective study of laparoscopic versus open gastric resection for gastric gastrointestinal stromal tumors based on the propensity score matching method

Authors: Chao Xu, Tao Chen, Yanfeng Hu, A. I. Balde, Hao Liu, Jiang Yu, Li Zhen, Guoxin Li

Published in: Surgical Endoscopy | Issue 1/2017

Login to get access

Abstract

Background

Surgical resection with a free margin is considered the gold standard for the treatment of gastric gastrointestinal stromal tumors (GISTs). Previous studies about the advantages of laparoscopic resection versus open surgery have generally been non-randomized and retrospective and have some obvious shortcomings that could influence the veracity and reliability of the results. Therefore, the aim of this study was to evaluate the efficacy of laparoscopic resection in the treatment of gastric GISTs using the propensity score matching (PSM) method.

Methods

Between 2005 and 2014, 217 consecutive patients undergoing laparoscopic or open resection for gastric GISTs were enrolled in a retrospective, single-center study. Patient and tumor characteristics, intraoperative and postoperative characteristics, and oncologic outcomes were collected from a database. The efficacy of the laparoscopic approach was analyzed using the PSM method by comparing the clinical parameters of patients who underwent laparoscopic (LAP) and open resection (OPEN) procedures.

Results

After PSM, 88 patients involved in the analysis (44 LAP vs. 44 OPEN) were randomly matched (1:1) by tumor size, localization, disease course, body mass index, age, and gender. The LAP group was clearly superior to the open group in terms of intraoperative indicators and postoperative short-term efficacy. The incidence of postoperative complications in the LAP group was lower than in the OPEN group (4.5 vs. 18.2 %, P = 0.044). A survival analysis showed that there was no significant difference in the disease-free survival time between the two groups (χ 2 = 0.211, P = 0.646).

Conclusion

These data should be processed using the PSM method in a non-randomized controlled trial (non-RCT) study. It is safe and feasible for patients with gastric GISTs up to 5 cm in size or located in the gastroesophageal junction to be treated with laparoscopic surgery.
Literature
3.
go back to reference Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, Suignard Y, Salameire D, Cellier D, Alberti L, Bringuier PP, Blay JY, Ray-Coquard I (2010) Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region. Bull Cancer 97:629–641. doi:10.1684/bdc.2010.1117 PubMed Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, Suignard Y, Salameire D, Cellier D, Alberti L, Bringuier PP, Blay JY, Ray-Coquard I (2010) Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region. Bull Cancer 97:629–641. doi:10.​1684/​bdc.​2010.​1117 PubMed
11.
go back to reference Takahashi T, Nakajima K, Miyazaki Y, Miyazaki Y, Kurokawa Y, Yamasaki M, Miyata H, Takiguchi S, Nishida T, Mori M, Doki Y (2015) Surgical strategy for the gastric gastrointestinal stromal tumors (GISTs) larger than 5 cm: laparoscopic surgery is feasible, safe, and oncologically acceptable. Surg Laparosc Endosc Percutaneous Tech 25:114–118. doi:10.1097/SLE.0000000000000039 CrossRef Takahashi T, Nakajima K, Miyazaki Y, Miyazaki Y, Kurokawa Y, Yamasaki M, Miyata H, Takiguchi S, Nishida T, Mori M, Doki Y (2015) Surgical strategy for the gastric gastrointestinal stromal tumors (GISTs) larger than 5 cm: laparoscopic surgery is feasible, safe, and oncologically acceptable. Surg Laparosc Endosc Percutaneous Tech 25:114–118. doi:10.​1097/​SLE.​0000000000000039​ CrossRef
12.
go back to reference West SG, Cham H, Thoemmes F, Renneberg B, Schulze J, Weiler M (2014) Propensity scores as a basis for equating groups: basic principles and application in clinical treatment outcome research. J Consult Clin Psychol 82:906–919. doi:10.1037/a0036387 CrossRefPubMed West SG, Cham H, Thoemmes F, Renneberg B, Schulze J, Weiler M (2014) Propensity scores as a basis for equating groups: basic principles and application in clinical treatment outcome research. J Consult Clin Psychol 82:906–919. doi:10.​1037/​a0036387 CrossRefPubMed
13.
go back to reference Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465. doi:10.1053/hupa.2002.123545 CrossRefPubMed Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O’Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459–465. doi:10.​1053/​hupa.​2002.​123545 CrossRefPubMed
14.
go back to reference Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer 103:821–829. doi:10.1002/cncr.20862 CrossRefPubMed Nilsson B, Bümming P, Meis-Kindblom JM, Odén A, Dortok A, Gustavsson B, Sablinska K, Kindblom LG (2005) Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era—a population-based study in western Sweden. Cancer 103:821–829. doi:10.​1002/​cncr.​20862 CrossRefPubMed
15.
go back to reference Casali PG, Jost L, Reichardt P, Schlemmer M, Blay J-Y (2009) Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl. 4):iv64–iv67. doi:10.1093/annonc/mdp131 Casali PG, Jost L, Reichardt P, Schlemmer M, Blay J-Y (2009) Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl. 4):iv64–iv67. doi:10.​1093/​annonc/​mdp131
19.
go back to reference Joensuu H (2002) Treatment of inoperable gastrointestinal stromal tumor (GIST) with imatinib (Glivec, Gleevec). Med Klin 97(Suppl. 1):28–30 Joensuu H (2002) Treatment of inoperable gastrointestinal stromal tumor (GIST) with imatinib (Glivec, Gleevec). Med Klin 97(Suppl. 1):28–30
21.
go back to reference Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626–632. doi:10.1200/JCO.2007.13.4452 CrossRefPubMed Blanke CD, Rankin C, Demetri GD, Ryan CW, von Mehren M, Benjamin RS, Raymond AK, Bramwell VH, Baker LH, Maki RG, Tanaka M, Hecht JR, Heinrich MC, Fletcher CD, Crowley JJ, Borden EC (2008) Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol 26:626–632. doi:10.​1200/​JCO.​2007.​13.​4452 CrossRefPubMed
22.
go back to reference Ashraf M, Jha J, Choudhry A, Aggarwal B, Nayak S, Chakraborty J, Majumder S, Biswas J (2011) Neoadjuvant and adjuvant therapy with imatinib for locally advanced gastrointestinal stromal tumors in eastern Indian patients. Asian Pac J Cancer Prev 12:2059–2064PubMed Ashraf M, Jha J, Choudhry A, Aggarwal B, Nayak S, Chakraborty J, Majumder S, Biswas J (2011) Neoadjuvant and adjuvant therapy with imatinib for locally advanced gastrointestinal stromal tumors in eastern Indian patients. Asian Pac J Cancer Prev 12:2059–2064PubMed
23.
go back to reference Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Pérol D, Blay JY, Le Cesne A (2011) Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer 11:72. doi:10.1186/1471-2407-11-72 CrossRefPubMedPubMedCentral Blesius A, Cassier PA, Bertucci F, Fayette J, Ray-Coquard I, Bui B, Adenis A, Rios M, Cupissol D, Pérol D, Blay JY, Le Cesne A (2011) Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer 11:72. doi:10.​1186/​1471-2407-11-72 CrossRefPubMedPubMedCentral
24.
go back to reference Fiore M, Palassini E, Fumagalli E, Pilotti S, Tamborini E, Stacchiotti S, Pennacchioli E, Casali PG, Gronchi A (2009) Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol 35:739–745. doi:10.1016/j.ejso.2008.11.005 CrossRefPubMed Fiore M, Palassini E, Fumagalli E, Pilotti S, Tamborini E, Stacchiotti S, Pennacchioli E, Casali PG, Gronchi A (2009) Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). Eur J Surg Oncol 35:739–745. doi:10.​1016/​j.​ejso.​2008.​11.​005 CrossRefPubMed
25.
go back to reference Kimata M, Kubota T, Otani Y, Ohgami M, Ishikawa Y, Yokoyama T, Issiki S, Abe S, Egawa T, Tokuyama J, Wada N, Kumai K, Kitajima M, Mukai M (2000) Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 30:177–180. doi:10.1007/s005950050038 CrossRefPubMed Kimata M, Kubota T, Otani Y, Ohgami M, Ishikawa Y, Yokoyama T, Issiki S, Abe S, Egawa T, Tokuyama J, Wada N, Kumai K, Kitajima M, Mukai M (2000) Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 30:177–180. doi:10.​1007/​s005950050038 CrossRefPubMed
29.
go back to reference Kasetsermwiriya W, Nagai E, Nakata K, Nagayoshi Y, Shimizu S, Tanaka M (2014) Laparoscopic surgery for gastric gastrointestinal stromal tumor is feasible irrespective of tumor size. J Laparoendosc Adv Surg Tech A 24:123–129. doi:10.1089/lap.2013.0433 CrossRefPubMed Kasetsermwiriya W, Nagai E, Nakata K, Nagayoshi Y, Shimizu S, Tanaka M (2014) Laparoscopic surgery for gastric gastrointestinal stromal tumor is feasible irrespective of tumor size. J Laparoendosc Adv Surg Tech A 24:123–129. doi:10.​1089/​lap.​2013.​0433 CrossRefPubMed
30.
go back to reference Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J (2014) Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc 28:2577–2583. doi:10.1007/s00464-014-3506-x CrossRefPubMed Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J (2014) Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc 28:2577–2583. doi:10.​1007/​s00464-014-3506-x CrossRefPubMed
31.
go back to reference NCCN (2015) NCCN clinical practice guidelines in oncology. Version 1 Fort Washington, Penn.: National Comprehensive Cancer Network, Inc. http://www.nccn.org NCCN (2015) NCCN clinical practice guidelines in oncology. Version 1 Fort Washington, Penn.: National Comprehensive Cancer Network, Inc. http://​www.​nccn.​org
33.
go back to reference Tagaya N, Mikami H, Kogure H, Kubota K, Hosoya Y, Nagai H (2002) Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction. Surg Endosc 16:177–179. doi:10.1007/s004640080158 CrossRefPubMed Tagaya N, Mikami H, Kogure H, Kubota K, Hosoya Y, Nagai H (2002) Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction. Surg Endosc 16:177–179. doi:10.​1007/​s004640080158 CrossRefPubMed
34.
go back to reference Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M (2007) NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)–update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(Suppl. 2):S1–S29PubMed Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, Corless CL, Debiec-Rychter M, DeMatteo RP, Ettinger DS, Fisher GA, Fletcher CD, Gronchi A, Hohenberger P, Hughes M, Joensuu H, Judson I, Le Cesne A, Maki RG, Morse M (2007) NCCN task force report: management of patients with gastrointestinal stromal tumor (GIST)–update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 5(Suppl. 2):S1–S29PubMed
Metadata
Title
Retrospective study of laparoscopic versus open gastric resection for gastric gastrointestinal stromal tumors based on the propensity score matching method
Authors
Chao Xu
Tao Chen
Yanfeng Hu
A. I. Balde
Hao Liu
Jiang Yu
Li Zhen
Guoxin Li
Publication date
01-01-2017
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2017
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4983-x

Other articles of this Issue 1/2017

Surgical Endoscopy 1/2017 Go to the issue